Advances in Oncology Template
Write in a clean editor, then format for Advances in Oncology in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Advances in Oncology format
Advances in Oncology is a peer-reviewed journal published by Elsevier, covering Ovarian cancer diagnosis and treatment, Glioma Diagnosis and Treatment, Cancer Genomics and Diagnostics.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Advances in Oncology 12 (2023) 45–58.
Formats any DOI in Advances in Oncology style. No sign-up. |
| Publishes research in | Ovarian cancer diagnosis and treatment Glioma Diagnosis and Treatment Cancer Genomics and Diagnostics CAR-T cell therapy research PARP inhibition in cancer therapy |
| ISSN | 2666-853X |
| Citation impact (2-yr) | 0.68 |
| h-index | 6 |
| i10-index | 2 |
| Total citations | 155 |
| Top institutions publishing here | Northwestern University |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Advances in Oncology per year
Citation impact of Advances in Oncology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Advances in Oncology
Urothelial carcinoma remains a difficult disease to treat, with high rates of recurrence and progression to advanced disease. Antibody–drug conjugates (ADCs) are a novel therapeutic option now available that have the potential to transform care for patients with urothelial carcinoma. As monotherapy, ADCs seem to offer advantages over standard chemotherapy regimens and immune checkpoint inhibitors…